These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23979232)

  • 1. [Life style-related disorders and independence in old patients - dyslipidemia].
    Eto M
    Nihon Ronen Igakkai Zasshi; 2013; 50(2):176-7. PubMed ID: 23979232
    [No Abstract]   [Full Text] [Related]  

  • 2. [Internal medicine and neurological diseases: progress in diagnosis and treatment. Topics: III. Dyslipidemia and neurological disorders (cerebral infarction, dementia)].
    Hanyu H
    Nihon Naika Gakkai Zasshi; 2012 Aug; 101(8):2188-94. PubMed ID: 22973689
    [No Abstract]   [Full Text] [Related]  

  • 3. Using cardiovascular age equivalent to close the treatment gap for dyslipidemia.
    Eaton CB
    Arch Intern Med; 2007 Nov; 167(21):2288. PubMed ID: 18039985
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: IV. Relation of NAFLD with lifestyle-related disease including obesity, dyslipidemia and hypertension].
    Kogiso T
    Nihon Naika Gakkai Zasshi; 2016 Jan; 105(1):31-7. PubMed ID: 27266041
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening and treatment of dyslipidemias in children and adolescents.
    Daniels SR
    Horm Res Paediatr; 2011; 76 Suppl 1():47-51. PubMed ID: 21778749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic dyslipidemia.
    Hayden MR
    J Cardiometab Syndr; 2006; 1(3):166-7. PubMed ID: 17679821
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholesterol, statins, and dementia: what the cardiologist should know.
    Wanamaker BL; Swiger KJ; Blumenthal RS; Martin SS
    Clin Cardiol; 2015 Apr; 38(4):243-50. PubMed ID: 25869997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis prevention and treatment in children and adolescents.
    Oliveira FL; Patin RV; Escrivão MA
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):513-28. PubMed ID: 20397826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle affects risk of two brain disorders.
    Health News; 2002 Nov; 8(11):7. PubMed ID: 12523252
    [No Abstract]   [Full Text] [Related]  

  • 10. Dyslipidemia in menopause: mechanisms and management.
    Schnatz PF; Schnatz JD
    Obstet Gynecol Surv; 2006 Sep; 61(9):608-13. PubMed ID: 16919179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Childhood obesity and dyslipidemia].
    Gómez-Díaz RA; Wacher-Rodarte NH
    Rev Med Inst Mex Seguro Soc; 2014; 52 Suppl 1():S102-8. PubMed ID: 24866316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipidemia as a therapeutic target for prevention of cardiovascular events and end-stage renal disease].
    Watanabe T
    Nihon Rinsho; 2008 Sep; 66(9):1761-9. PubMed ID: 18788407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction is difficult, particularly about the future.
    Jackson R; Wells S
    Arch Intern Med; 2007 Nov; 167(21):2286-7. PubMed ID: 18039984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of vascular risk factors].
    Hanyu H
    Nihon Ronen Igakkai Zasshi; 2012; 49(3):284-7. PubMed ID: 23268964
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bone diseases caused by impaired glucose and lipid metabolism].
    Kanazawa I; Sugimoto T
    Clin Calcium; 2013 Nov; 23(11):1605-11. PubMed ID: 24162600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2018 new recommendations for dyslipidemia : a critical review of evidence].
    Aubert CE; Rodondi N
    Rev Med Suisse; 2018 Feb; 14(596):456-460. PubMed ID: 29489125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment for dyslipidemia and the prevention of dementia].
    Kobayashi K; Yokote K
    Nihon Rinsho; 2011 Dec; 69 Suppl 10 Pt 2():197-201. PubMed ID: 22755183
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
    Srikanth S; Deedwania P
    Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atherogenic dyslipidemia and residual risk. State of the art in 2014].
    Millán Núñez-Cortés J; Pedro-Botet Montoya J; Pintó Sala X;
    Clin Investig Arterioscler; 2014; 26(6):287-92. PubMed ID: 25450326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accounting for individual differences in risk of Alzheimer disease.
    Grant W
    PLoS Med; 2005 Mar; 2(3):e82; author reply e86. PubMed ID: 15783264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.